Skip to main content
JSW Dulux Limited logo

JSW Dulux Limited — Investor Relations & Filings

Ticker · JSWDULUX ISIN · INE133A01011 BSE.NS Manufacturing
Open in API
Filings indexed 2,253 across all filing types
Latest filing 2024-10-31 Regulatory Filings
Country IN India
Listing BSE.NS JSWDULUX

About JSW Dulux Limited

https://www.jswpaints.in/

JSW Dulux Limited specializes in the development, manufacture, and distribution of a comprehensive range of decorative and industrial coating solutions. The company’s portfolio includes interior and exterior emulsions, protective finishes, enamels, and specialized wood coatings designed for both residential and commercial applications. Utilizing advanced chemical formulations, the organization focuses on delivering high-performance products characterized by durability, color precision, and environmental sustainability. Key offerings feature low-VOC compositions, weather-resistant technologies, and anti-microbial properties. The company serves a broad market spectrum, providing technical coating systems for infrastructure projects alongside consumer-grade paints. Its operations emphasize innovation in surface protection and aesthetic enhancement through rigorous research and development.

Recent filings

Filing Released Lang Actions
Please find attached our response to the clarification sought by the exchange.
Regulatory Filings Classification · 95% confidence The document is a series of communications and announcements from Akzo Nobel India Limited and its ultimate holding company Akzo Nobel N.V. The content includes a clarification letter responding to a query from the stock exchange, a disclosure under SEBI regulations about a portfolio review focusing on Deco South Asia, and a media release announcing the strategic review. The document does not contain any financial statements, detailed financial performance data, or management analysis. It primarily serves as a regulatory disclosure and public announcement about a strategic review and potential future corporate actions. There is no indication of this being an annual report, interim report, earnings release, or any detailed financial or governance report. The document is more aligned with a regulatory announcement or general corporate disclosure. Given the nature of the content and the absence of detailed financial data or report attachments, the most appropriate classification is Regulatory Filings (RNS).
2024-10-31 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication from Akzo Nobel India Limited dated 30th October 2024, addressed to stock exchanges (BSE and NSE). It concerns the issue of duplicate share certificates under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content includes a register of new share certificates issued on duplication, listing folio numbers, shareholder names, and certificate details. There is no financial data, earnings information, management discussion, or audit content. The document is a regulatory compliance announcement related to share certificate issuance and does not fit into financial reports or management reports categories. It is not a report publication announcement since it contains substantive information about share certificate issuance. The closest fitting category is "Regulatory Filings (RNS)" as it is a general regulatory announcement about compliance with SEBI regulations and share certificate issuance.
2024-10-30 English
Pls find attached details of duplicate share certificates issued.
Regulatory Filings Classification · 95% confidence The document is an official communication from Akzo Nobel India Limited dated 30th October 2024, addressed to stock exchanges (BSE and NSE). It concerns the issuance of duplicate share certificates under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content includes detailed registers of new share certificates issued on duplication, listing folio numbers, shareholder names, and share details. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is a regulatory compliance announcement related to share certificate issuance and does not fit into financial reports or management reports categories. It is a formal intimation to the stock exchanges about share certificate duplication processing, which aligns with the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-10-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification from Akzo Nobel India Limited about an upcoming group conference call to discuss the financial results for the quarter ended 30th September 2024 (Q2 FY 2024-25). It includes details about the call date, time, participants, and contact information. There is no actual financial data or detailed report content included, only an invitation and announcement of the call. This matches the definition of a Call Transcript (CT) document type, as it is related to a conference call about earnings results. However, since this is only an invitation to the call and not the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement about the call, not the transcript or the earnings release itself. The document length is short (2634 characters), and it does not contain financial statements or substantive financial data, so it is not an Interim Report or Earnings Release. Therefore, the best fit is Regulatory Filings (RNS).
2024-10-30 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides details about a litigation matter involving the Income Tax Department and the company, including the financial implications and management's view on the outcome. The document is short (2954 characters) and serves as an announcement or intimation of a regulatory matter rather than a full report or detailed financial statement. It does not contain financial statements or detailed analysis but is a regulatory disclosure about litigation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-30 English
Please find attached intimation of investor meet scheduled for 7th November 2024
Call Transcript Classification · 90% confidence The document is a formal notification from Akzo Nobel India Limited to stock exchanges about an upcoming group conference call to discuss the financial results for the quarter ended 30th September 2024 (Q2 FY 2024-25). It includes details about the date, time, and participants of the call, as well as contact information. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of a conference call related to earnings results, not the earnings release or the transcript itself. Therefore, the document fits the category of a Call Transcript (CT) announcement or invitation. However, since it is an invitation to a conference call rather than the transcript, and given the classification options, the best fit is Call Transcript (CT) as it relates directly to the earnings call event.
2024-10-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.